» Articles » PMID: 2418910

Selective Activation of Mesolimbic and Mesocortical Dopamine Metabolism in Rat Brain by Infusion of a Stable Substance P Analogue into the Ventral Tegmental Area

Overview
Journal Brain Res
Specialty Neurology
Date 1986 Jan 15
PMID 2418910
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Microinfusion of the metabolically stable substance P (SP) agonist, [pGlu5,MePhe8,Sar9]-SP5-11 (DiMe-C7), into the ventral tegmental area (VTA) of rat brain increased levels of the dopamine (DA) metabolite dihydroxyphenylacetic acid in the prefrontal cortex (+ 120%) and nucleus accumbens (+30%) but not in other regions of forebrain. In contrast, infusions of DiMe-C7 or SP into the lateral ventricles or microinfusions of SP into VTA failed to elicit increases in DOPAC levels in forebrain. DA levels were unaffected by SP or DiMe-C7 regardless of the route of administration. These data and previous studies suggest a role for endogenous SP in the modulation of mesocortical and mesolimbic DA neurones.

Citing Articles

Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.

Vadnie C, Park J, Abdel Gawad N, Ho A, Hinton D, Choi D Front Neurosci. 2014; 8:288.

PMID: 25278825 PMC: 4166902. DOI: 10.3389/fnins.2014.00288.


Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Robinson J, Fish E, Krouse M, Thorsell A, Heilig M, Malanga C Psychopharmacology (Berl). 2011; 220(1):215-24.

PMID: 21909635 PMC: 3484369. DOI: 10.1007/s00213-011-2469-z.


Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.

Gariepy H, Couture R Br J Pharmacol. 2010; 161(8):1868-84.

PMID: 20804497 PMC: 3010589. DOI: 10.1111/j.1476-5381.2010.01008.x.


Neuronal pathways linking substance P to drug addiction and stress.

Commons K Brain Res. 2009; 1314:175-82.

PMID: 19913520 PMC: 4028699. DOI: 10.1016/j.brainres.2009.11.014.


Responses of limbic and extrapyramidal substance P systems to nicotine treatment.

Alburges M, Frankel P, Hoonakker A, Hanson G Psychopharmacology (Berl). 2008; 201(4):517-27.

PMID: 18773198 PMC: 2678878. DOI: 10.1007/s00213-008-1316-3.